Medical News

RSS

APC-300 drug significantly inhibits pancreatic cancer cell growth: Adamis

Adamis Pharmaceuticals Corporation announced today that in addition to its activity in prostate cancer, its drug APC-300 significantly inhibits the growth of pancreatic cancer cells.

25 Mar 2011

New study implicates microRNAs in panic disorder

A new study published in the current issue of Biological Psychiatry now implicates one type of molecular switch, microRNAs, in panic disorder.

25 Mar 2011

Children with epilepsy more likely to have psychiatric symptoms

A newly published report reveals that children with epilepsy are more likely to have psychiatric symptoms, with gender a determining factor in their development.

25 Mar 2011

Researchers create hand and finger gesture controlled microscope

The multitouch microscope integrates two Finnish innovations and brings new dimensions into teaching and research.

25 Mar 2011

FDA approves Medtronic's Consulta and Syncra pacemaker systems

Medtronic, Inc. today announced that the U.S. Food & Drug Administration has approved its Consulta and Syncra cardiac resynchronization therapy-pacemaker systems.

25 Mar 2011

Study finds significant increase in MRSA infections during summer, autumn months

A new study from Rhode Island Hospital has found a significant increase in the occurrence of methicillin-resistant Staphylococcus aureus infections in the summer and autumn months.

25 Mar 2011

Young adults with religious involvement more likely to become obese in middle-age

Could it be the potato salad? Young adults who frequently attend religious activities are 50 percent more likely to become obese by middle age as young adults with no religious involvement, according to new Northwestern Medicine research.

25 Mar 2011

VARI, Gentel Biosciences receive U.S. Patent for new glycan detection technology

Gentel Biosciences, a leader in proteomics tools, and Van Andel Research Institute, a biomedical research institute, jointly announce today the granting of U.S. Patent 7,838,634 for a new method to profile changes in the glycosylation of proteins captured on the surface of an antibody array slide. Gentel first obtained an exclusive right to commercialize the technology in 2006.

25 Mar 2011

Oncolytics completes patient enrollment in REOLYSIN Phase 2 trial against head, neck cancers

Oncolytics Biotech Inc. today announced that it has completed patient enrollment in its U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN in combination with paclitaxel and carboplatin in patients with advanced head and neck cancers.

25 Mar 2011

HDL, BG Medicine to offer galectin-3 testing services for patients with heart failure

Health Diagnostic Laboratory, Inc. and BG Medicine, Inc., announced today an agreement under which HDL, Inc. will offer galectin-3 testing services based on the BG Medicine Galectin-3 Test.

25 Mar 2011

Viewpoints: Sebelius, Vilsack, Weiner defend reform law; pro/con on seniors' access to health care

As former governors from states with large rural populations, we cheered this new health-care law. We knew that it would give Americans more freedom in their health-care choices, lower costs and improve the quality of care, especially for those in rural communities.

25 Mar 2011

Clinical trial to determine whether Crestor can prevent new colon tumors after surgery

Christiana Care Health System's Helen F. Graham Cancer Center is leading a national clinical trial to determine if Crestor, a cholesterol-lowering drug, can prevent new colon tumors from forming after colon cancer surgery.

25 Mar 2011

Boehringer Ingelheim formally acquires Amgen's Fremont manufacturing site

Today Boehringer Ingelheim formally acquired Amgen's biopharmaceutical development and manufacturing facility in Fremont, California. This acquisition involves leasing buildings, acquiring physical equipment and assuming manufacturing processes done at the Fremont site.

25 Mar 2011

Scientists develop new software to test alterations in night vision

Researchers from the Department of Optics of the University of Granada, belonging to the Laboratorio de Ciencias de la Visi-n y Aplicaciones, have developed a programme for testing alterations in night vision, and the tool required to implement it, which has been named "halometer".

25 Mar 2011

Scientists discover hormone pathway that can lead to new diabetes treatment

Researchers at UT Southwestern Medical Center have discovered a hormone pathway that potentially could lead to new ways of treating type 1 diabetes independent of insulin, long thought to be the sole regulator of carbohydrates in the liver.

25 Mar 2011

AltheRx purchases all assets related to Solabegron from GlaxoSmithKline

AltheRx Inc., a privately-held clinical development company, announced today that it has purchased all assets related to Solabegron from GlaxoSmithKline. Solabegron is a highly selective and potent beta3-adrenoceptor agonist that has demonstrated positive results in Phase II clinical programs for the treatment of Overactive Bladder in women and Irritable Bowel Syndrome.

25 Mar 2011

Sitagliptin drug can slow onset of diabetes

Diabetes type 2 is caused by insufficient levels of insulin to keep blood glucose under control. Excessive levels of another hormone, glucagon, can also contribute to diabetes type 2 by causing the liver to flood the body with stored glucose.

25 Mar 2011

Positive results from Tarsa's oral calcitonin Phase III trial against postmenopausal osteoporosis

Tarsa Therapeutics today announced that the Phase III ORACAL trial of its oral recombinant salmon calcitonin in the treatment of postmenopausal osteoporosis was successfully concluded and yielded statistically significant, positive top-line results.

25 Mar 2011

Merck & Co receives FDA approval for Zostavax vaccine to treat shingles

The Food and Drug Administration today approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older.

25 Mar 2011

Mercury in fish may not increase heart disease risk: Study

According to a new study Americans' level of exposure to mercury from sources such as fish is not associated with a higher risk of heart disease, stroke or other cardiovascular disease. This is in spite of the repeated proofs of neurological deficits in children and unborn babies due to mercury exposure.

24 Mar 2011

Medical News

APC-300 drug significantly inhibits pancreatic cancer cell growth: Adamis

New study implicates microRNAs in panic disorder

Children with epilepsy more likely to have psychiatric symptoms

Researchers create hand and finger gesture controlled microscope

FDA approves Medtronic's Consulta and Syncra pacemaker systems

Study finds significant increase in MRSA infections during summer, autumn months

Young adults with religious involvement more likely to become obese in middle-age

VARI, Gentel Biosciences receive U.S. Patent for new glycan detection technology

Oncolytics completes patient enrollment in REOLYSIN Phase 2 trial against head, neck cancers

HDL, BG Medicine to offer galectin-3 testing services for patients with heart failure

Viewpoints: Sebelius, Vilsack, Weiner defend reform law; pro/con on seniors' access to health care

Clinical trial to determine whether Crestor can prevent new colon tumors after surgery

Boehringer Ingelheim formally acquires Amgen's Fremont manufacturing site

Scientists develop new software to test alterations in night vision

Scientists discover hormone pathway that can lead to new diabetes treatment

AltheRx purchases all assets related to Solabegron from GlaxoSmithKline

Sitagliptin drug can slow onset of diabetes

Positive results from Tarsa's oral calcitonin Phase III trial against postmenopausal osteoporosis

Merck & Co receives FDA approval for Zostavax vaccine to treat shingles

Mercury in fish may not increase heart disease risk: Study

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News